Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability (Q78106230)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

title

Glutathione reverses endothelial dysfunction and improves nitric oxide bioavailability (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference

1 reference

5

A A Quyyumi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

A Prasad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

N P Andrews

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

F A Padder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

M Husain

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

language of work or name

English

0 references

publication date

1 August 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

507-514

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

The Role of Endothelium in Cardiovascular Homeostasis and Diseases

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

The oxidation hypothesis of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

High Glucose Increases Nitric Oxide Synthase Expression and Superoxide Anion Generation in Human Aortic Endothelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Biological chemistry of thiols in the vasculature and in vascular-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Aspirin improves endothelial dysfunction in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Contribution of nitric oxide to reactive hyperemia: impact of endothelial dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Nitric oxide activity in the atherosclerotic human coronary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Contribution of Nitric Oxide to Metabolic Coronary Vasodilation in the Human Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Intracoronary infusion of reduced glutathione improves endothelial vasomotor response to acetylcholine in human coronary circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

N-acetylcysteine does not influence the activity of endothelium-derived relaxing factor in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Selective modification of glutathione metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Glutathione-dependent protection against oxidative injury

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Biochemical characterization of a membrane-bound enzyme responsible for generating nitric oxide from nitroglycerin in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Mechanisms responsible for the heterogeneous coronary microvascular response to nitroglycerin

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Nitric oxide generation from nitroprusside by vascular tissue. Evidence that reduction of the nitroprusside anion and cyanide loss are required

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside, and nitrosoguanidine--inhibition by calcium, lanthanum, and other cations, enhancement by thiols

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2899%2900216-8

7 January 2021

10.1016/S0735-1097(99)00216-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10440166%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference